02.05.2018 00:44:00
|
WeissLaw LLP: DCT Industrial Trust Inc. Acquisition May Not Be in the Best Interests of DCT Shareholders
NEW YORK, May 1, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of DCT Industrial Trust Inc. ("DCT" or the "Company") (NYSE: DCT) in connection with the proposed merger of the Company with Prologis, Inc. ("PLD") (NYSE: PLD) in a stock-for stock transaction valued at approximately $8.4 billion, inclusive of debt. Under the terms of the agreement, the Company's shareholders will be entitled to receive 1.02 shares of PLD for each DCT share they own, representing consideration of $65.39 based on PLD's April 30 opening price.
WeissLaw is investigating whether DCT's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $67.00 per DCT share. Additionally, the Company recently announced positive financial results. It reported signed leases totaling 2.5 million square feet, reflecting a 35% increase in rental rates on a straight line basis.
Given these facts, WeissLaw is investigating whether DCT shareholders will obtain their fair and proportionate share of the Company's continued success and growth prospects. If you own DCT shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/dct-industrial-trust-inc/
View original content:http://www.prnewswire.com/news-releases/weisslaw-llp-dct-industrial-trust-inc-acquisition-may-not-be-in-the-best-interests-of-dct-shareholders-300640634.html
SOURCE WeissLaw LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AngioDynamics Inc.mehr Nachrichten
07:01 |
Ausblick: AngioDynamics veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
01.01.25 |
NASDAQ Composite Index-Wert AngioDynamics-Aktie: So viel hätten Anleger mit einem Investment in AngioDynamics von vor 5 Jahren verloren (finanzen.at) | |
25.12.24 |
NASDAQ Composite Index-Titel AngioDynamics-Aktie: So viel Verlust hätte eine AngioDynamics-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
24.12.24 |
Pluszeichen in New York: NASDAQ Composite klettert zum Handelsende (finanzen.at) | |
24.12.24 |
Zuversicht in New York: NASDAQ Composite-Anleger greifen am Nachmittag zu (finanzen.at) | |
24.12.24 |
Freundlicher Handel: NASDAQ Composite-Anleger greifen am Dienstagmittag zu (finanzen.at) | |
24.12.24 |
Erste Schätzungen: AngioDynamics mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
19.12.24 |
Gute Stimmung in New York: NASDAQ Composite-Anleger greifen nachmittags zu (finanzen.at) |
Analysen zu AngioDynamics Inc.mehr Analysen
Aktien in diesem Artikel
AngioDynamics Inc. | 8,75 | 1,16% | |
Prologis Inc. | 102,52 | 0,35% |